ANIP — ANI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for ANI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	100	48.2	221	151	295
Net Total Accounts Receivable
Net Total Receivables	129	165	162	222	281
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	322	344	520	528	753
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	52.7	43.2	44.6	56.9	62.5
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	772	760	904	1,284	1,440
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	87.5	99.4	145	194	278
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	413	422	447	856	900
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	359	339	458	429	541
Total Liabilities & Shareholders' Equity	772	760	904	1,284	1,440
Total Common Shares Outstanding
Total Preferred Shares Outstanding